Fung J - Search Results

1

Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: implications for antiviral therapy.

Fung J, Seto WK, Lai CL, Yuen J, Wong DK, Yuen MF. Fung J, et al. J Hepatol. 2011 Feb;54(2):195-200. doi: 10.1016/j.jhep.2010.06.031. Epub 2010 Oct 19. J Hepatol. 2011. PMID: 21056499

2

Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma.

Wong DK, Yuen MF, Poon RT, Yuen JC, Fung J, Lai CL. Wong DK, et al. Among authors: fung j. J Hepatol. 2006 Oct;45(4):553-9. doi: 10.1016/j.jhep.2006.05.014. Epub 2006 Jun 23. J Hepatol. 2006. PMID: 16904225

3

One-year entecavir or lamivudine therapy results in reduction of hepatitis B virus intrahepatic covalently closed circular DNA levels.

Wong DK, Yuen MF, Ngai VW, Fung J, Lai CL. Wong DK, et al. Among authors: fung j. Antivir Ther. 2006;11(7):909-16. Antivir Ther. 2006. PMID: 17302253 Clinical Trial.

4

Significance of viral load, core promoter/precore mutations and specific sequences of polymerase gene in HBV-infected patients on 3-year lamivudine treatment.

Yuen MF, Sablon E, Libbrecht E, Van De Velde H, Wong DK, Fung J, Wong BC, Lai CL. Yuen MF, et al. Among authors: fung j. Antivir Ther. 2006;11(6):779-86. Antivir Ther. 2006. PMID: 17310822 Clinical Trial.

5

Adefovir dipivoxil monotherapy and combination therapy with lamivudine for the treatment of chronic hepatitis B in an Asian population.

Fung J, Lai CL, Yuen JC, Wong DK, Tanaka Y, Mizokami M, Yuen MF. Fung J, et al. Antivir Ther. 2007;12(1):41-6. Antivir Ther. 2007. PMID: 17503746

6

Etiologies of chronic liver diseases in Hong Kong.

Fung KT, Fung J, Lai CL, Yuen MF. Fung KT, et al. Among authors: fung j. Eur J Gastroenterol Hepatol. 2007 Aug;19(8):659-64. doi: 10.1097/MEG.0b013e3281ace0b7. Eur J Gastroenterol Hepatol. 2007. PMID: 17625435

7

Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection.

Wong DK, Tanaka Y, Lai CL, Mizokami M, Fung J, Yuen MF. Wong DK, et al. Among authors: fung j. J Clin Microbiol. 2007 Dec;45(12):3942-7. doi: 10.1128/JCM.00366-07. Epub 2007 Oct 17. J Clin Microbiol. 2007. PMID: 17942661 Free PMC article.

8

Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response.

Yuen MF, Fong DY, Wong DK, Yuen JC, Fung J, Lai CL. Yuen MF, et al. Among authors: fung j. Hepatology. 2007 Dec;46(6):1695-703. doi: 10.1002/hep.21939. Hepatology. 2007. PMID: 18027877

9

Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.

Yuen MF, Seto WK, Chow DH, Tsui K, Wong DK, Ngai VW, Wong BC, Fung J, Yuen JC, Lai CL. Yuen MF, et al. Among authors: fung j. Antivir Ther. 2007;12(8):1295-303. Antivir Ther. 2007. PMID: 18240869 Clinical Trial.

10

Prevalence of fibrosis and cirrhosis in chronic hepatitis B: implications for treatment and management.

Fung J, Lai CL, But D, Wong D, Cheung TK, Yuen MF. Fung J, et al. Am J Gastroenterol. 2008 Jun;103(6):1421-6. doi: 10.1111/j.1572-0241.2007.01751.x. Epub 2008 Apr 16. Am J Gastroenterol. 2008. PMID: 18422821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,022 results

Search Page

Filters